Safety-net providers once often overcharged for medications covered under the federal cost-saving program have a new resource to protect against it.
The Health Resources & Services Administration (HRSA) has launched a new secure website intended to serve as a tool through which safety-net healthcare providers participating in the 340B federal drug pricing program can determine the maximum prices pharmaceutical companies can charge them for medications sold to them under the program, Administration officials announced this week.
In 2010, HRSA noted in a press release, Congress mandated that the government calculate and list such “ceiling prices” following reports by the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) that documented a pattern of overcharges. That legislation also created civil monetary penalties for drug manufacturers that “knowingly and intentionally” overcharge safety-net hospitals for 340B drugs.
The penalties took effect in January 2019.
“Today marks a positive milestone in the history of the 340B drug pricing program,” 340B Health President and CEO Maureen Testoni said in a statement. “Today’s launch of a secure website listing the maximum allowable prices for all 340B covered drugs brings a healthy dose of sunshine into a marketplace that has, for far too long, been a black box. Until today, hospitals, clinics, and health centers participating in 340B had no way to be sure they were paying the correct amount for the drugs they purchase.”
Testoni will be the featured guest on today’s edition of Monitor Mondays, the weekly healthcare news web broadcast produced by RACmonitor.
Annual spending in the 340B program has reportedly approached $20 billion during recent years, or approximately triple the rate of a decade ago. That sum represents a little more than 5 percent of all domestic drug sales.
In the past, Testoni noted, those payments undoubtedly amounted to considerably more than was allowable under the program.
“The Department of Health and Human Services (HHS) Office of Inspector General (OIG) has documented numerous instances of drug manufacturers overcharging safety-net providers for lifesaving medicines through 340B, undercutting resources designed to provide care to patients in need,” she said. “This overcharging led Congress to direct the Health Resources & Services Administration (HRSA) to create (this) secure website, where the agency can post the 340B ceiling price for every drug sold to those providers. It has taken nine years to see that law turned into action, but we are pleased to see it happen.”
“Starting today,” Testoni added, “authorized personnel working for 340B providers can check the HRSA website and ascertain whether they are being charged the correct amounts. With this new transparency comes a needed increase in accountability for drug manufacturers. When this information is combined with the civil monetary penalty authority that Congress granted HRSA, manufacturers that knowingly and intentionally charge safety-net providers too much will be subject to financial penalties.”
Testoni singled out HRSA’s Office of Pharmacy Affairs and its leader, Captain Krista Pedley, for making it all possible.
For more information about the 340B program, including access to periodic updates and a series of FAQs, go online to https://www.hrsa.gov/opa/index.html.
Programming Note:
Listen to Maureen Testoni report this story live during today’s Monitor Monday, 10-10:30 a.m. EST.
Coders may very well feel that they have no impact on hospitals under H.R.1, the so-called One Big Beautiful Bill Act (OBBBA). Just the opposite
Many hospitals that participate in the 340B Drug Pricing Program faced a dilemma as their Medicaid census fell or was projected to fall below the
Please log in to your account to comment on this article.
Uncover essential coding insights with nationally recognized coding authority Kay Piper, RHIA, CDIP, CCS. Through ICD10monitor’s interactive, on‑demand webcast series, Kay walks you through the AHA’s 2026 ICD‑10‑CM/PCS Quarterly Coding Clinics, translating each update into practical, easy‑to‑apply guidance designed to sharpen precision, ensure compliance, and strengthen day‑to‑day decision‑making. Available shortly after each official release.
Uncover critical guidance on the ICD-10-CM/PCS code updates. Kay Piper reviews and explains ICD-10-CM/PCS coding guidelines in the AHA’s fourth quarter 2026 ICD-10-CM/PCS Coding Clinic in an easy to access on-demand webcast.
Uncover critical guidance on the ICD-10-CM/PCS code updates. Kay Piper reviews and explains ICD-10-CM/PCS coding guidelines in the AHA’s third quarter 2026 ICD-10-CM/PCS Coding Clinic in an easy to access on-demand webcast.
Uncover critical guidance on the ICD-10-CM/PCS code updates. Kay Piper reviews and explains ICD-10-CM/PCS coding guidelines in the AHA’s second quarter 2026 ICD-10-CM/PCS Coding Clinic in an easy to access on-demand webcast.
Federal auditors are intensifying their focus on inpatient psychiatric facilities, using advanced data analytics to spotlight outliers and pursue high‑dollar repayments. In this high‑impact webcast, Michael Calahan, PA, MBA, Compliance Officer and V.P., Hospital & Physician Compliance, breaks down what regulators are really targeting in IPF-PPS admissions, documentation, treatment and discharge planning. Attendees will learn practical steps to tighten processes, avoid common audit triggers and protect reimbursement and reduce the risk of multimillion-dollar repayment demands.
In this timely session, Stacey Shillito, CDIP, CPMA, CCS, CCS-P, CPEDC, COPC, breaks down the complexities of Medical Decision Making (MDM) documentation so providers can confidently capture the true complexity of their care. Attendees will learn practical, efficient strategies to ensure documentation aligns with current E/M guidelines, supports accurate coding, and reduces audit risk, all without adding to charting time.
Join Ronald Hirsch, MD, FACP, CHCQM for The PEPPER Returns – Risk and Opportunity at Your Fingertips, a practical webcast that demystifies the PEPPER and shows you how to turn complex claims data into actionable insights. Dr. Hirsch will explain how to interpret key measures, identify compliance risks, uncover missed revenue opportunities, and understand new updates in the PEPPER, all to help your organization stay ahead of audits and use this powerful data proactively.
Stay ahead of the 2026-2027 audit surge with “Top 10 Audit Targets for 2026-2027 for Hospitals & Physicians: Protect Your Revenue,” a high-impact webcast led by Michael Calahan, PA, MBA. This concise session gives hospitals and physicians clear insight into the most likely federal audit targets, such as E/M services, split/shared and critical care, observation and admissions, device credits, and Two-Midnight Rule changes, and shows how to tighten documentation, coding, and internal processes to reduce denials, recoupments, and penalties. Attendees walk away with practical best practices to protect revenue, strengthen compliance, and better prepare their teams for inevitable audits.
Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →
BLOOM INTO SAVINGS! Get 25% OFF during our spring sale through March 27. Use code SPRING26 at checkout to claim this offer.
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
